{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T06:32:35Z","timestamp":1793514755397,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:00:00Z","timestamp":1467158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:00:00Z","timestamp":1467158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fundaci\u00f3 Marat\u00f3 de TV3","award":["20141610"],"award-info":[{"award-number":["20141610"]}]},{"name":"Fondo de Investigaciones Sanitarias, FEDER","award":["15\/00377"],"award-info":[{"award-number":["15\/00377"]}]},{"name":"Fondo de Investigaciones Sanitarias","award":["FIS 14\/00203"],"award-info":[{"award-number":["FIS 14\/00203"]}]},{"name":"CIBERER","id":[{"id":"https:\/\/ror.org\/01ygm5w19","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH RO1NS077851"],"award-info":[{"award-number":["NIH RO1NS077851"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00401-016-1591-8","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T06:05:28Z","timestamp":1467180328000},"page":"531-543","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":226,"title":["Neuropathological criteria of anti-IgLON5-related tauopathy"],"prefix":"10.1007","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2948-4187","authenticated-orcid":false,"given":"Ellen","family":"Gelpi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"H\u00f6ftberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Graus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice L.","family":"Holton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janja","family":"Pretnar-Oblak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"H\u00f6gl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Schmutzhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Poewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerda","family":"Ricken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Dalmau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Budka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Revesz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor G.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,29]]},"reference":[{"key":"1591_CR1","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100\u00a0years. J Neuropathol Exp Neurol 70:960\u2013969","journal-title":"J Neuropathol Exp Neurol"},{"key":"1591_CR2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/mds.26608","volume":"31","author":"N Br\u00fcggemann","year":"2016","unstructured":"Br\u00fcggemann N, Wandinger KP, Gaig C, St\u00f6cker W, Junghanns K, Helmchen C et al (2016) Dystonia, lower limb stiffness and upward gaze palsy in a patient with IgLON5 antibodies. Mov Disord 31:762\u2013764","journal-title":"Mov Disord"},{"key":"1591_CR3","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I et al (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755\u2013766","journal-title":"Acta Neuropathol"},{"key":"1591_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/9781444341256.ch15","volume-title":"Neurodegeneration: the molecular pathology of dementia and movement disorders","author":"DW Dickson","year":"2011","unstructured":"Dickson DW, Hauw JJ, Agid Y, Litvan I (2011) Progressive supranuclear palsy and corticobasal degeneration. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Wiley\u2013Blackwell Publishers, New York, pp 135\u2013155","edition":"2"},{"key":"1591_CR5","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1523\/JNEUROSCI.5261-09.2010","volume":"30","author":"M Dutschmann","year":"2010","unstructured":"Dutschmann M, Menuet C, Stettner GM, Gestreau C, Borghgraef P, Devijver H et al (2010) Upper airway dysfunction of Tau-P301L mice correlates with tauopathy in midbrain and ponto-medullary brainstem nuclei. J Neurosci 30:1810\u20131821","journal-title":"J Neurosci"},{"key":"1591_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2008.05.069","volume":"1224","author":"T Hashimoto","year":"2008","unstructured":"Hashimoto T, Yamada M, Maekawa S, Nakashima T, Miyata S (2008) IgLON cell adhesion molecule Kilon is a crucial modulator for synapse number in hippocampal neurons. Brain Res 1224:1\u201311","journal-title":"Brain Res"},{"key":"1591_CR7","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0140-6736(15)60445-7","volume":"385","author":"B H\u00f6gl","year":"2015","unstructured":"H\u00f6gl B, Heidbreder A, Santamaria J, Graus F, Poewe W (2015) IgLON5 autoimmunity and abnormal behaviours during sleep. Lancet 385:1590","journal-title":"Lancet"},{"key":"1591_CR8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/9781444341256.ch24","volume-title":"Neurodegeneration: the molecular pathology of dementia and movement disorders","author":"JL Holton","year":"2011","unstructured":"Holton JL, Lees AJ, Revesz T (2011) Multiple system atrophy. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Wiley\u2013Blackwell Publishers, New York, pp 242\u2013252","edition":"2"},{"key":"1591_CR9","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/jnen\/61.12.1040","volume":"61","author":"T Ishizawa","year":"2002","unstructured":"Ishizawa T, Ko LW, Cookson N, Davias P, Espinoza M, Dickson DW (2002) Selective neurofibrillary degeneration of the hippocampal CA2 sector is associated with four-repeat tauopathies. Neuropathol Exp Neurol 61:1040\u20131047","journal-title":"Neuropathol Exp Neurol"},{"key":"1591_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.neurol.2007.09.007","volume":"164","author":"E Kaphan","year":"2008","unstructured":"Kaphan E, Pellissier JF, Rey M, Robert D, Auphan M, Ali Ch\u00e9rif A (2008) Esophageal achalasia, sleep disorders and chorea in a tauopathy without ophthalmoplegia, parkinsonian syndrome, nor dementia (progressive supranuclear palsy?): clinicopathological study. Rev Neurol (Paris) 164:377\u2013383","journal-title":"Rev Neurol (Paris)"},{"key":"1591_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.12208","volume":"41","author":"GG Kovacs","year":"2015","unstructured":"Kovacs GG (2015) Neuropathology of tauopathies: principles and practice. Neuropathol Appl Neurobiol 41:3\u201323","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1591_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","volume":"131","author":"GG Kovacs","year":"2016","unstructured":"Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H et al (2016) Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol 131:87\u2013102","journal-title":"Acta Neuropathol"},{"key":"1591_CR13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/jnnp.52.5.643","volume":"52","author":"HG Lidov","year":"1989","unstructured":"Lidov HG, Duchen LW, Thomas PK, Thrush DC (1989) Progressive medullary failure associated with neurofibrillary degeneration. J Neurol Neurosurg Psychiatry 52:643\u2013647","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 1","key":"1591_CR14","first-page":"710","volume":"30","author":"MT Montojo","year":"2015","unstructured":"Montojo MT, Piren V, Benkhadra F, Codreanu A, Wirtz G, Kerschen P et al (2015) Mimicking progressive supranuclear palsy and causing Tako-Tsubo syndrome: a case report on IgLON5 encephalopathy [abstract]. Mov Disord 30(Suppl 1):710","journal-title":"Mov Disord"},{"key":"1591_CR15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1136\/jnnp.2008.169029","volume":"81","author":"J Pretnar-Oblak","year":"2010","unstructured":"Pretnar-Oblak J, Zaletel M, Hajnsek TM, Meglic B, Hocevar-Boltezar I, Popovic M (2010) Isolated bulbar paralysis in a patient with medullar tau pathology: a case report. J Neurol Neurosurg Psychiatry 81:847\u2013849","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1591_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","volume":"13","author":"L Sabater","year":"2014","unstructured":"Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E et al (2014) A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 13:575\u2013586","journal-title":"Lancet Neurol"},{"key":"1591_CR17","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1212\/NXI.0000000000000136","volume":"2","author":"MM Simabukuro","year":"2015","unstructured":"Simabukuro MM, Sabater L, Adoni T, Cury RG, Haddad MS, Moreira CH et al (2015) Sleep disorder, chorea, and dementia associated with IgLON5 antibodies. Neurol Neuroimmunol Neuroinflamm 2:e136","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1591_CR18","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/brain\/awm104","volume":"130","author":"DR Williams","year":"2007","unstructured":"Williams DR, Holton JL, Strand C, Pittman A, de Silva R, Lees AJ et al (2007) Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson\u2019s syndrome. Brain 130:1566\u20131576","journal-title":"Brain"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-016-1591-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-016-1591-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-016-1591-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T08:43:45Z","timestamp":1589618625000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-016-1591-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,29]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["1591"],"URL":"https:\/\/doi.org\/10.1007\/s00401-016-1591-8","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,29]]},"assertion":[{"value":"22 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was partly supported by grants from Fundaci\u00f3 Marat\u00f3 de TV3 to EG (grant no. 20141610), Fondo de Investigaciones Sanitarias, FEDER, (FIS 15\/00377, FG), (FIS 14\/00203, JD) and CIBERER (JD), Madrid, Spain, Fundaci\u00f3 CELLEX (JD), and NIH RO1NS077851 (JD).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"JD receives royalties from licensing fees to Athena diagnostics for a patent for the use of Ma2 and autoantibody test, and from licensing fees to Euroimmun for patents for the use of NMDAR and GABAbR as autoantibody tests, and licensing fees for the use of DPPX, GABAaR, and IgLON5 antibodies as diagnostic tests. JD has received a research grant from Euroimmun. FG receives royalties from licensing fees to Euroimmun for the use of IgLON5 as a diagnostic test.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"EG, RH, HL, JH, TD, MP, JP, BH, GR, JS, HB, TR, GK declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}